von Boguslawski K - Search Results

1

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.

Jahkola T, Toivonen T, Virtanen I, von Smitten K, Nordling S, von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C. Jahkola T, et al. Among authors: von smitten k, von boguslawski k. Br J Cancer. 1998 Dec;78(11):1507-13. doi: 10.1038/bjc.1998.714. Br J Cancer. 1998. PMID: 9836485 Free PMC article.

2

Tenascin-C expression correlates with prognosis in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: von boguslawski k. Oncology. 2003;64(3):245-50. doi: 10.1159/000069305. Oncology. 2003. PMID: 12697965

3

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: von boguslawski k. Int J Cancer. 2001 Jan 20;95(1):1-6. doi: 10.1002/1097-0215(20010120)95:1<1::aid-ijc1000>3.0.co;2-5. Int J Cancer. 2001. PMID: 11241302 Free article.

4

p27 expression correlates with short-term, but not with long-term prognosis in breast cancer.

Leivonen M, Nordling S, Lundin J, von Boguslawski K, Haglund C. Leivonen M, et al. Among authors: von boguslawski k. Breast Cancer Res Treat. 2001 May;67(1):15-22. doi: 10.1023/a:1010623326118. Breast Cancer Res Treat. 2001. PMID: 11518462

5

STn and prognosis in breast cancer.

Leivonen M, Nordling S, Lundin J, von Boguslawski K, Haglund C. Leivonen M, et al. Among authors: von boguslawski k. Oncology. 2001;61(4):299-305. doi: 10.1159/000055337. Oncology. 2001. PMID: 11721177

6

Prognostic value of syndecan-1 expression in breast cancer.

Leivonen M, Lundin J, Nordling S, von Boguslawski K, Haglund C. Leivonen M, et al. Among authors: von boguslawski k. Oncology. 2004;67(1):11-8. doi: 10.1159/000080280. Oncology. 2004. PMID: 15459490

7

The prognostic value of p27 in gastric cancer.

Wiksten JP, Lundin J, Nordling S, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: von boguslawski k. Oncology. 2002;63(2):180-4. doi: 10.1159/000063813. Oncology. 2002. PMID: 12239454

8

Long-term prognostic impact of immunohistochemical estrogen receptor determinations compared with biochemical receptor determination in primary breast cancer.

Blomqvist C, von Boguslawski K, Stenman UH, Mäenpää H, von Smitten K, Nordling S. Blomqvist C, et al. Among authors: von boguslawski k, von smitten k. Acta Oncol. 1997;36(5):530-2. doi: 10.3109/02841869709001310. Acta Oncol. 1997. PMID: 9292751 No abstract available.

9

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.

Tynninen O, Sjöström J, von Boguslawski K, Bengtsson NO, Heikkilä R, Malmström P, Ostenstad B, Wist E, Valvere V, Saksela E, Paavonen T, Blomqvist C. Tynninen O, et al. Among authors: von boguslawski k. Br J Cancer. 2002 Jun 17;86(12):1905-8. doi: 10.1038/sj.bjc.6600325. Br J Cancer. 2002. PMID: 12085184 Free PMC article. Clinical Trial.

10

Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.

Juuti A, Nordling S, Louhimo J, Lundin J, von Boguslawski K, Haglund C. Juuti A, et al. Among authors: von boguslawski k. Oncology. 2003;65(4):371-7. doi: 10.1159/000074651. Oncology. 2003. PMID: 14707458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page